Emerging Therapies Explained: Blood Test for Brain Tumours

Dec. 2023BRAIN TUMOUR RESEARCH

Datar Cancer Genetics and Cromwell Hospital's Second Opinion Service

Oct. 2023Cromwell Hospital Newsroom

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumours

Dec. 2023 CISION PR Newswire

'Game-Changer' Blood Test Detects Breast Cancer

'Game-changer' blood test detects breast cancer earlier than X-rays, study shows

Jul. 2022Independent

Landmark Liquid Biopsy Study

Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer Study establishes the high clinical performance of 'Trucheck^™ - Breast' blood test.

Jul. 2022EIN Presswire

The London Clinic News

Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services

Apr. 2022EIN Presswire

FDA News: Prostate Cancer

Datar's TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation

Feb. 2022Precision Medicine

The Healthcare Technology Report

The Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande - Datar Cancer Genetics)

Oct, 2021 The Healthcare Technology

NICE - UK

UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood^™- Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game-C

Jul, 2021 CISION PR Newswire

South Africa: News

'Groundbreaking' high-sensitivity cancer-screening test arriving in SA ahead of World Cancer Day

Feb. 2022IOL

Kuwait: News

Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait

Dec. 2021Arab Newswire

FDA News: Breast Cancer

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics

Nov, 2022CISION PR Newswire

Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor

Feb. 2025New Leadership in Cancer Care: Dr. Cristofanilli Joins DCG

Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers

Feb. 2025Personalized Cancer Care: DCG Introduces AI-Driven Platform

Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients

Jan. 2025Real-Time Video Reveals Chemo Effectiveness in Vitro

Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring

Jan. 2025Detecting Minimal Residual Disease Earlier with Dual-Approach Blood Test